DIGEZYME
DIGEZYME, licence 80060391: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Sabinsa Canada Inc.
- NPN or DIN-HM
- 80060391
- Status
- Active licence
- Licence date
- 28 April 2015
- Revision date
- 29 July 2025
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 10.0 % | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 1200.0 FCC DU | Not calculated |
| Protéase bactérien Source : Bacillus licheniformis - cellule entière | 10.0 % | Not calculated |
| Protéase bactérien Source : Bacillus licheniformis - cellule entière | 300.0 FCC PC | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma reesei - en entier | 10.0 % | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma reesei - en entier | 55.0 FCC CU | Not calculated |
| bêta-D-galactoside galactohydrolase Source : Aspergillus flavus var. oryzae - En entier | 10.0 % | Not calculated |
| bêta-D-galactoside galactohydrolase Source : Aspergillus flavus var. oryzae - En entier | 200.0 FCC ALU | Not calculated |
| Triacylglycérol lipase Source : Aspergillus flavus var. oryzae - En entier | 10.0 % | Not calculated |
| Triacylglycérol lipase Source : Aspergillus flavus var. oryzae - En entier | 10.0 FIP LU | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Dioxyde de silicium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1.0 Comprimé ; maximum: 2.0 Comprimé | minimum: 2.0 Tous les jours ; maximum: 3.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
DIGESTIVE ENZYMES.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
HYPERSENSITIVITY/ ALLERGY HAS BEEN KNOWN TO OCCUR; IN SUCH A CASE , DISCONTINUE USE.
- Précautions et mises en garde
IF YOU ARE PREGNANT OR BREASTFEEDING, CONSULT A HEALTH CARE PRACTITIONER PRIOR TO USE. IF YOU HAVE DIABETES, CONSULT A HEALTH CARE PRACTITIONER PRIOR TO USE. IF YOU HAVE GASTROINTESTINAL LESIONS, ULCERS, ARE TAKING ANTICOAGULANT AGENTS OR ANTI-INFLAMMATORY AGENTS, OR HAVING SURGERY, CONSULT A HEALTHCARE PRACTITIONER PRIOR TO USE.
Source
Official Health Canada record, licence 80060391
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.